×
About 125 results

ALLMedicine™ N-terminal Telopeptide Center

Research & Reviews  45 results

The Effects of Milk Supplementation on Bone Health Indices in Adults: A Meta-analysis o...
https://doi.org/10.1093/advances/nmab136
Advances in Nutrition (Bethesda, Md.); Hidayat K, Chen JS et. al.

Nov 19th, 2021 - Milk contains a number of bone-beneficial nutrients. However, milk, due to D-galactose contents, might have unfavorable effects on bone health. A meta-analysis of randomized controlled trials (RCTs) was performed to clarify the effects of milk sup...

Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated wi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608777
Osteoporosis International : a Journal Established as Res... Seefried L, Rak D et. al.

Jul 4th, 2021 - There is limited understanding of how asfotase alfa affects mineral metabolism and bone turnover in adults with pediatric-onset hypophosphatasia. This study showed that adults with hypophosphatasia treated with asfotase alfa experienced significan...

Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone dens...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078791
PloS One; Ishida N, Higuchi T et. al.

Apr 28th, 2021 - The serum N-terminal telopeptide of type I collagen (NTx) is significantly higher in patients with Crohn disease (CD) than in healthy individuals and patients with ulcerative colitis. This study aimed to investigate whether an elevated serum NTx l...

Comparing children and adults with chronic nonbacterial osteomyelitis.
https://doi.org/10.1097/BOR.0000000000000734
Current Opinion in Rheumatology; Lenert A, Ferguson PJ

Aug 4th, 2020 - To describe the main clinical differences of children and adults with chronic nonbacterial osteomyelitis (CNO). CNO is a severe systemic autoinflammatory syndrome characterized by multiple bone lesions because of inflammatory osteitis. Delay to di...

A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Catheps...
https://doi.org/10.1007/s10928-020-09699-9
Journal of Pharmacokinetics and Pharmacodynamics; Zajic S, Stoch SA et. al.

Jul 11th, 2020 - To develop a framework for evaluating the resorption effects of Cathepsin K (CatK) inhibitors and to inform dose regimen selection, a pharmacokinetic/pharmacodynamic (PK/PD) model for odanacatib (ODN) was developed based upon data from Phase 1 stu...

see more →

Clinicaltrials.gov  3 results

Prospective Evaluation of Biomarkers Variability in Knee Prosthetic Surgery
https://clinicaltrials.gov/ct2/show/NCT01971931

Jan 22nd, 2020 - Aseptic implant loosening after TKR causes knee pain, reduces knee function and may require revision surgery. Several proteins have been identified, which are involved in bone metabolism and remodelling; variations in serum levels of some of these...

The Effects of DHA on Periodontitis
https://clinicaltrials.gov/ct2/show/NCT01976806

Dec 13th, 2017 - The primary aim of this study is to investigate the effect of docosahexaenoic acid (DHA; 2 gm/day) plus low dose aspirin (ASA 81 mg/day)compared to ASA alone on periodontitis over three months. Our hypothesis is that DHA plus ASA will improve peri...

The Effect of Chymosin on the Intestinal Absorption of Calcium
https://clinicaltrials.gov/ct2/show/NCT01370941

Mar 21st, 2012 - Background: Osteoporosis is a frequent disease. Allegedly, more than 500,000 Danes are diagnosed with osteoporosis and, in consequence, seems every year more than 20,000 fractures. A number of factors are known to increase the risk of osteoporosis...

see more →

News  2 results

Eldecalcitol may increase bone mineral density in poor responders to bisphosphonates
https://www.mdedge.com/obgyn/article/204583/osteoporosis/eldecalcitol-may-increase-bone-mineral-density-poor-responders
Jake Remaly

Jul 13th, 2019 - Among patients with osteoporosis who have diminished long-term response to bisphosphonate therapy, the addition of eldecalcitol may reduce bone turnover markers and increase bone mineral density, according a study in Osteoporosis and Sarcopenia. B.

Once-weekly teriparatide still achieves bone mineral density gains
https://www.mdedge.com/familymedicine/article/204503/osteoporosis/once-weekly-teriparatide-still-achieves-bone-mineral?channel=39313
MDedge Endocrinology; Bianca Nogrady

Jul 11th, 2019 - Once-weekly subcutaneous injections of the osteoporosis drug teriparatide still achieve increases in bone mineral density, according to a postmarketing observational study published online in Osteoporosis and Sarcopenia. Teriparatide is widely use.

see more →